Eyeworld Daily News

2019 ASCRS•ASOA San Diego Daily Sunday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/1116415

Contents of this Issue

Navigation

Page 49 of 72

MAY 5, 2019 | EYEWORLD DAILY NEWS | 49 ONSITE laser trabeculoplasty (SLT) in the patient's right eye. "The pressure was not budging," she said. That led her to use a subconjunctival gel stent via an ab externo approach along with 40 mcg of mitomy- cin-C (MMC). This helped lower the patient's preop IOP of 18 mm Hg lower to 8 mm Hg postop. Arsham Sheybani, MD, St. Louis, reported on a 74-year- old male patient with primary open-angle glaucoma (POAG) with an IOP of 23 mm Hg in the right eye and using several medi- cations. The patient also had a pri- mary tube shunt. The visual acuity was 20/30, and the visual field was progressing. "With a mild patient, it's tough to justify trabeculectomy. There's where devices can help," Dr. Sheybani said. The patient was treated with subconjuncti- val MIGS and MMC. By postop month 9, the IOP was 13 mm Hg, with no medications used. Cataract surgeon Deborah Gess Ristvedt, DO, Alexandria, Minnesota, shared details on a 76-year-old male patient who had POAG in both eyes, diagnosed in 2013, and visual acuity of 20/40 and 20/30. The patient also had cataracts. He was on three medi- cations. His maximum IOPs were 21 and 22, and his visual field was worsening. For her cataract and MIGS treatment, Dr. Ristvedt considered an angle procedure, aqueous suppression, or a subcon- junctival approach but ultimately chose subconjunctival MIGS. Jonathan Myers, MD, Phil- adelphia, discussed a 73-year-old patient with OAG and age-related macular degeneration as well as an IOP of 32 mm Hg in the right eye and 15 mm Hg in the left eye. The patient, who was on maximum medical therapy, said, "I ran out of timolol last week." "This is a cry for help," Dr. Myer said, noting that comments like that often indicate that pa- tients are not taking medication as they should. The patient also had prior SLT, phaco, and an iStent (Glaukos) in the right eye. Dr. Myers used a XEN Gel Stent (Allergan) ab interno with MMC in the right eye, which worked great for awhile. However, the patient then had an IOP of 27 mm Hg on maximum medical therapy with a flat bleb. He ulti- mately performed needling, and the patient had a buttonhole and subconjunctival heme. Dr. Myers used the XEN via an ab externo approach. At the patient's last fol- low up 3 weeks ago, his IOPs were 10 and 12 mm Hg, and he was not on any medications. Editors' note: This event was supported by educational grants from Allergan and Santen Pharmaceutical. NexTech 49 continued from page 48 Maximize Efficiency with the Most Intuitive Ophthalmology EMR Nextech.com/Ophthalmology (800) 868-3694 NEW Accurate Coding IMPROVED Knowledge Base NEW Assisted Compliance IntelleChartPRO IntelleChartPRO DISCOVER New & Enhanced Features at ASCRS Booth #1833

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Daily News - 2019 ASCRS•ASOA San Diego Daily Sunday